Telix Pharmaceuticals Limited (ASX:TLX)
Share Price and News


Company Profile:

Telix Pharmaceuticals Limited (ASX: TLX) under health care sector is engaged into the commercializing and development of molecularly targeted radiation (MTR) products for the treatment of cancer. It is based out of Flemington road, North Melbourne, Australia. The company’s incorporation year was 2017 and is categorized as a bio-pharmaceutical company. Products such as TLX-250, TLX-591 and TLX-101 are included in company’s MTR range.



Code : ASX:TLX Healthcare Company


Telix Pharmaceuticals Limited (ASX:TLX) Latest News